Project 2, Risk Factors for Fractures Among the Elderly, complements this Program Project Grant (PPG) by providing a population perspective on risk factors for age-related fractures. In each of our Aims, we propose to continue our focus on identifying risk factors for long-term fracture outcomes by conducting large, historical cohort studies of Olmsted County (OC), Minnesota residents. Such studies are made possible by the unique medical-records linkage system of the Rochester Epidemiology Project (REP) infrastructure, through which complete information (inpatient and outpatient) on medical care of OC residents is available. We will further strengthen our interpretation of results from these large cohort studies by directly measuring bone density and microstructure as well as performing comprehensive assessments of additional risk factors for fractures in the relavent population groups being studied in each Aim.
In Aim 1, we will focus on updating the fracture risk in a common age-related comorbid condition, heart failure (HF), given recent data suggesting that HF patients on ?-blockers (which recently has become the standard-of-care) may, in fact, now be protected against low bone density and fractures. By performing a comprehensive evaluation of fracture risk in individuals with chronic HF in the era of widespread ?-blocker therapy, we will address the central theme of this PPG, sympathetic nervous system (SNS) control of bone metabolism, and complement the work being performed by the other Projects in this PPG, which are evaluating the detrimental effects on bone of increased sympathetic activation (also an underlying mechanism for HF) and potential beneficial effects of ?-blockers (which antagonize sympathetic activation) on bone metabolism.
In Aim 2, we will expand on our prior work by now performing a systematic examination of all comorbid conditions in older OC residents in order to improve fracture risk assessment. Using innovative analytic techniques, we will describe the emergence and interrelation of multiple comorbidities with aging and test whether specific fractures are preceded by different comorbidity clusters, and specifically examine how they may affect bone density. These population-based studies will fill important gaps in our knowledge and provide novel insights on age-related fracture risk.

Public Health Relevance

Project 2 will determine if patients with heart failure receiving ?-blocker therapy are still at increased risk for fractures. We will also gain knowledge related to the emergence and interaction of multiple comorbidities with aging and whether it will improve prediction of fragility fractures.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG004875-35
Application #
9692596
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
35
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Bower, James H; Grossardt, Brandon R; Rocca, Walter A et al. (2018) Prevalence of and indications for antipsychotic use in Parkinson's disease. Mov Disord 33:325-328
Rocca, Walter A; Grossardt, Brandon R; Brue, Scott M et al. (2018) Data Resource Profile: Expansion of the Rochester Epidemiology Project medical records-linkage system (E-REP). Int J Epidemiol 47:368-368j
Xu, Ming; Pirtskhalava, Tamar; Farr, Joshua N et al. (2018) Senolytics improve physical function and increase lifespan in old age. Nat Med 24:1246-1256
Khosla, Sundeep; Farr, Joshua N; Kirkland, James L (2018) Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis. J Clin Endocrinol Metab 103:1282-1290
Rocca, Walter A (2018) The future burden of Parkinson's disease. Mov Disord 33:8-9
Rocca, Walter A; Gazzuola Rocca, Liliana; Smith, Carin Y et al. (2018) Personal, reproductive, and familial characteristics associated with bilateral oophorectomy in premenopausal women: A population-based case-control study. Maturitas 117:64-77
Drake, Matthew T; Fenske, Jennifer S; Blocki, Frank A et al. (2018) Validation of a novel, rapid, high precision sclerostin assay not confounded by sclerostin fragments. Bone 111:36-43
Laughlin-Tommaso, Shannon K; Khan, Zaraq; Weaver, Amy L et al. (2018) Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause 25:483-492
Farr, Joshua N; Weivoda, Megan M; Nicks, Kristy M et al. (2018) Osteoprotection Through the Deletion of the Transcription Factor Ror? in Mice. J Bone Miner Res 33:720-731
Wenning, Gregor; Trojanowski, John Q; Kaufmann, Horacio et al. (2018) Is multiple system atrophy an infectious disease? Ann Neurol 83:10-12

Showing the most recent 10 out of 401 publications